Pfizer Soars 19% To All-Time High After Parent Firm’s Vaccine Trials
Pfizer said its COVID-19 vaccine, developed in association with the German partner BioNTech SE, was more than 90 per cent effective against SARS-CoV-2.
Pfizer said its COVID-19 vaccine, developed in association with the German partner BioNTech SE, was more than 90 per cent effective against SARS-CoV-2.